ronapreve
roche registration gmbh - casirivimab, imdevimab - covid-19 virus infection - imunitní séra a imunoglobuliny, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. viz kapitoly 4. 4 a 5.
dasatinib msn 100mg potahovaná tableta
msn labs europe limited, paola array - 17512 dasatinib - potahovaná tableta - 100mg - dasatinib
dasatinib msn 140mg potahovaná tableta
msn labs europe limited, paola array - 17512 dasatinib - potahovaná tableta - 140mg - dasatinib
dasatinib msn 20mg potahovaná tableta
msn labs europe limited, paola array - 17512 dasatinib - potahovaná tableta - 20mg - dasatinib
dasatinib msn 50mg potahovaná tableta
msn labs europe limited, paola array - 17512 dasatinib - potahovaná tableta - 50mg - dasatinib
dasatinib msn 70mg potahovaná tableta
msn labs europe limited, paola array - 17512 dasatinib - potahovaná tableta - 70mg - dasatinib
dasatinib msn 80mg potahovaná tableta
msn labs europe limited, paola array - 17512 dasatinib - potahovaná tableta - 80mg - dasatinib